Interpretive criteria for disk diffusion susceptibility testing of mupirocin, a topical antibiotic.

Journal of Clinical Microbiology
P C FuchsA L Barry

Abstract

Five hundred gram-positive clinical bacterial isolates were tested for susceptibility to mupirocin by broth microdilution and disk diffusion methods (5- and 10-micrograms disks). All but 1 of 330 staphylococci (including 100 oxacillin-resistant Staphylococcus aureus) were susceptible to less than or equal to 1.0 micrograms of mupirocin per ml. With a susceptible MIC breakpoint of less than or equal to 2.0 micrograms/ml, the corresponding zone diameter breakpoints were greater than or equal to 14 mm for 5-micrograms disks and greater than or equal to 16 mm for 10-micrograms disks. With either disk potency, susceptible staphylococci were effectively separated from more resistant gram-positive species such as the enterococci and gram-positive bacilli.

References

Aug 1, 1989·Antimicrobial Agents and Chemotherapy·H RodeS Cywes
Mar 1, 1986·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill
Apr 1, 1985·Antimicrobial Agents and Chemotherapy·R SutherlandA R White
May 1, 1985·The Journal of Antimicrobial Chemotherapy·M W Casewell, R L Hill

❮ Previous
Next ❯

Citations

Sep 24, 2004·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·O MelterH de Lencastre
Sep 4, 2008·The Journal of Antimicrobial Chemotherapy·Xavier MalaviolleMarc J Struelens
Jan 9, 2009·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·E NulensR H Deurenberg
May 1, 2009·Emerging Infectious Diseases·Ruud H DeurenbergEllen E Stobberingh
Jun 18, 2011·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·D MithoeA V M Möller
Oct 7, 2011·Journal of Clinical Microbiology·E M BarrosM Giambiagi-Demarval
Jun 1, 1993·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W Witte, I Klare
Dec 6, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M Semret, M A Miller
Jun 20, 2007·Journal of Medical Microbiology·Naira Elane Moreira de OliveiraMarcia Giambiagi-deMarval
Jul 1, 1993·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·M C LaytonJ E Patterson
Feb 12, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C F M van der DonkE E Stobberingh
Jun 5, 2013·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·C F M van der DonkE E Stobberingh
Mar 11, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Fernando ChavesJoaquín R Otero
Dec 15, 2010·The British Journal of General Practice : the Journal of the Royal College of General Practitioners·Michelle Ia RijndersEllen E Stobberingh
Aug 5, 2000·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·J E VasquezF A Sarubbi
Dec 6, 2017·Asian Pacific Journal of Tropical Medicine·Ebru Şebnem Yılmaz, Özkan Aslantaş
Oct 23, 2010·Indian Journal of Medical Microbiology·S K OommenK Jinsha
May 1, 1997·Antimicrobial Agents and Chemotherapy·J E FinlayJ A Poupard
Sep 1, 1993·Antimicrobial Agents and Chemotherapy·D A JanssenC A Kauffman
Jul 1, 1993·Journal of Clinical Microbiology·A L BarryP C Fuchs

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.